CD40LG and cancer: Further, past studies support the implication of sCD40L in PDAC pathogenesis by exhibiting the cancer-related coagulopathy (Trousseau’s syndrome) in PDAC[18], and by showing the effect of anti-platelet therapy to control PDAC metastasis in nude mice[25].